Next Science Limited announced that Non-Executive Director, Bruce Hancox, is to step down from the Board with effect from 30 June 2023. Bruce has been involved with Next Science for the past 12 years and provided sage advice
and guidance through that period to assist the business to now approach a positive inflexion point on its business and financial performance. Bruce has served on the Board for over a decade, and chaired the Audit and Risk Committee, as a non-independent director. He has represented the mutual interests of all shareholders and of its major shareholder, associated interests of Mr. Langley Walker. In the interim, Aileen Stockburger, who has been with Next Science since before the IPO and is an existing member of the Audit and Risk Committee, will become the Committee Chair. Next Science will now commence a search for at least one new independent non-executive director, which may include adding a US based director.